Back to 
AssetMark, Inc.
AssetMark, Inc.
ARWR
Showing 7 of 21 quarters
Position history for AssetMark, Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.
Yes. AssetMark holds 2,228 shares of ARWR (Arrowhead Pharmaceuticals), worth $145,823, as of its Q3 2026 13F filing. It reduced the position by 22 shares (-1.0%) from Q2 2026. AssetMark has held ARWR since Q3 2025, across 5 quarterly 13F filings.
Current Value
$145,823
Current Shares
2,228
Total Value Change
+$145,710
Total Shares Change
+2,222
Quarter-by-Quarter History